Guillain Barre syndrome and Myasthenia Gravis

1. THE 2-MINUTE PHYSIOLOGY (Rapid Pathophysiology)

• The Core Mechanism: Guillain-Barré Syndrome (GBS) and Myasthenia Gravis (MG) represent critical neuromuscular emergencies, but they strike at entirely different anatomical targets.
• Guillain-Barré Syndrome (GBS): This is a rapidly progressive neuropathy that attacks the peripheral spinal nerve bundle, directly knocking out motor, sensory, and autonomic function. It is an immune-mediated demyelinating or axonal injury classically triggered by an antecedent infection such as Campylobacter, Cytomegalovirus (CMV), Epstein-Barr Virus (EBV), or Mycoplasma.
• Myasthenia Gravis (MG): This is a disorder strictly localized to the neuromuscular junction (NMJ). The immune system mistakenly produces autoantibodies that destroy post-synaptic acetylcholine (ACh) receptors on the muscular membrane. Because it is purely an NMJ blockade, the patient suffers from fatigable motor weakness with absolutely no sensory loss.

2. THE BEDSIDE ACTION PLAN (Rapid ER Management)

• Immediate Respiratory Stabilization: Secure the ABCs, establish IV access, and place the patient on continuous cardiac monitoring. Do not wait for clinical hypoxia; proactively measure the Forced Vital Capacity (FVC) and Negative Inspiratory Force (NIF) to detect impending ventilatory failure.
• GBS Dysautonomia Management: Autonomic neuropathy is common and lethal in GBS. Treat symptomatic bradycardia with Atropine and be prepared to initiate external cardiac pacing for 2nd- or 3rd-degree heart blocks. Treat hypotension with IV fluids and positioning; treat hypertension with short-acting antihypertensives.
• Targeted Immunotherapy: The mainstay of emergency treatment for both severe GBS and myasthenic crisis is Intravenous Immune Globulin (IVIG) or Plasma Exchange. In GBS, IVIG is dosed at 0.4 grams/kg/day for 5 days.

3. THE DIAGNOSTIC GRID (Differential Diagnosis & Workup)

• "Can't-Miss" Mimics:
• Botulism: A pre-synaptic NMJ disease presenting with descending weakness and bulbar signs (dysarthria, dry mouth, dysphagia).
• Spinal Cord Compression: Presents with extremity weakness but usually features a distinct sensory level, bowel/bladder incontinence, and upper motor neuron signs.
• Tick Paralysis: Another critical pre-synaptic NMJ mimic causing ascending paralysis.
• Cholinergic Crisis: Overtreatment of MG with acetylcholinesterase inhibitors can mimic a myasthenic crisis.
• Prioritized Diagnostic Workup:
• Pulmonary Function: Serial bedside FVC, NIF, end-tidal CO2, and ABG (PCO2) to track respiratory decompensation.
• Lumbar Puncture (for GBS): Look for classic CSF pleocytosis (albuminocytologic dissociation), though it may be normal early in the disease course.
• Trigger Search: Actively seek out an infectious or metabolic trigger that may have precipitated the myasthenic crisis.

4. THE VISUAL BOARD (ECG / POCUS / Imaging)

• GBS Physical Exam: Actively look for acute, ascending, symmetrical weakness accompanied by the definitive loss of deep tendon reflexes (DTRs). Urinary retention is common, but you must perform a rectal exam to confirm anal sphincter tone is preserved (differentiating it from a spinal cord lesion).
• MG Physical Exam: Look for fatigable, symmetrical proximal weakness, facial weakness, and bilateral ptosis, while noting that pupils are strictly spared.
• Fatigability Tests: Ask the patient to maintain an upward gaze for 30 seconds to see if ptosis emerges/worsens, or have them flap their arms like a chicken wing 30 times and retest strength.
• The Ice Pack Test: Applying an ice bag over a ptotic eye can dramatically improve symptoms and aid bedside diagnosis.
• The Miller-Fisher Variant (GBS): Visually confirm the classic triad of ataxia, areflexia, and ophthalmoplegia (usually presenting as diplopia).

5. THE SCORING MATRIX (Risk Stratification & Guidelines)

• The Respiratory Intubation Thresholds: An FVC < 20 mL/kg or a NIF < 30 cm H2O strictly indicates impending ventilatory failure and mandates early endotracheal intubation.
• Admission Criteria: Any patient suspected of GBS with ascending paralysis, or any MG patient with truncal involvement and concern for respiratory compromise, must be admitted to the Intensive Care Unit (ICU) for close monitoring.

6. THE DANGER ZONE (Pitfalls & Critical Actions)

• Deadly Cognitive Trap (Administering Exacerbating Drugs): Giving a myasthenic patient standard ED medications that trigger a catastrophic respiratory crisis. Critical Action: Strictly avoid beta-blockers, calcium channel blockers, aminoglycosides, fluoroquinolones, tetracyclines, and macrolides in patients with known neuromuscular junction disease.
• Deadly Cognitive Trap (Misdiagnosing the Crisis): Failing to differentiate a myasthenic crisis from a cholinergic crisis. Critical Action: Both present with respiratory distress. A cholinergic crisis (overtreatment) features profound parasympathetic excess—bradycardia, excessive sweating, hypersalivation, and severe abdominal discomfort. Conversely, myasthenic crisis (undertreatment) is much more likely to present with mydriasis and an inability to tolerate secretions due to pure weakness.
• Procedural Pitfall (Ignoring the Monitor in GBS): Fixating on the weakness and missing the dysautonomia. Critical Action: GBS causes profound variations in heart rate and blood pressure; continuous EKG monitoring is mandated to catch fatal AV blocks.

7. MCQ MASTERCLASS (Written Exam Tips)

• High-Yield Buzzwords: "Ascending weakness," "absent deep tendon reflexes," and "antecedent Campylobacter infection" point definitively to GBS. "Fatigable proximal weakness," "ptosis with spared pupils," and "improves with ice pack" point directly to MG.
• The Intubation Distractor: A question describes an MG or GBS patient breathing at 24 breaths/min with an oxygen saturation of 98%. Distractor options will suggest "Supplemental oxygen" or "BiPAP." Correction: You must look at the objective parameters. If the question gives an FVC < 20 mL/kg or NIF < 30 cm H2O, the correct answer is always "Endotracheal intubation" regardless of their current oxygen saturation.
• The Sensory Distractor: A patient presents with acute generalized weakness. The distractor claims a sensory level at T4. Correction: GBS has variable sensory loss, but MG and Botulism have absolutely zero sensory loss. A sharp sensory level indicates a spinal cord lesion, not a peripheral neuropathy.

8. THE BOARDROOM SCRIPT (OSCE & Oral Board Tips)

• The Initial Assessment Hook: "Given the patient's presentation of progressive, fatigable weakness with ptosis, I am highly concerned for a Myasthenic Crisis. Conversely, if I found ascending weakness and absent deep tendon reflexes, Guillain-Barré Syndrome would be my primary diagnosis. I must immediately rule out an acute spinal cord compression."
• The Resuscitation Command: "I will secure the ABCs, place the patient on a continuous cardiac monitor to watch for dysrhythmias, and withhold any potential exacerbating drugs like fluoroquinolones or beta-blockers. Because respiratory failure is the primary threat, I am ordering immediate bedside measurements of the patient's Forced Vital Capacity (FVC) and Negative Inspiratory Force (NIF)."
• The Definitive Pivot: "The patient's FVC is rapidly declining below 20 mL/kg, indicating impending diaphragmatic failure. I am preparing for early endotracheal intubation. I will initiate Intravenous Immune Globulin (IVIG) and consult neurology for emergent admission to the Intensive Care Unit."